ADC Therapeutics SA
Change company Symbol lookup
Select an option...
ADCT ADC Therapeutics SA
JNJ Johnson & Johnson
AVGO Broadcom Inc
GILD Gilead Sciences Inc
LLY Eli Lilly and Co
ABBV Abbvie Inc
CIEN Ciena Corp
TEAM Atlassian Corp
MRO Marathon Oil Corp
TRGP Targa Resources Corp
Go

Health Care : Biotechnology | Small Cap Value
Based in Switzerland
Company profile

ADC Therapeutics SA is a Switzerland-based clinical-stage oncology drug discovery and development company. It develops antibody drug conjugates (ADCs) for the treatment of both solid and hematological cancers. It employs monoclonal antibodies specific to particular tumor antigens conjugated to a class of pyrrolobenzodiazepine (PBD)-based warheads to selectively target and kill cancer cells. The Company has multiple PBD-based ADCs in ongoing clinical trials, ranging from first in human to pivotal Phase II clinical trials, and numerous preclinical ADCs in development. Its main drug candidates are ADCT-301 for the treatment of lymphoma and leukemia and ADCT-402 for the treatment of non-Hodgkin’s lymphoma and B-cell leukemia. It serves customers in the United States, Switzerland, and the United Kingdom.

Price
Delayed
$2.95
Day's Change
0.075 (2.61%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.99
Day's Low
2.77
Volume
(Average)

Today's volume of 123,913 shares is on pace to be in-line with ADCT's 10-day average volume of 526,344 shares.

123,913

Upcoming Events

ADCT's fiscal year ends in December
There are no upcoming events for ADCT

Past Earnings

This page reports .
DateEvent descriptionEarnings per
share actual
Earnings
estimate range
Previous year's
actual
November 8, 2022Q3 2022 Earnings Release-$0.65-$1.00 to $0.41-$0.93
August 9, 2022Q2 2022 Earnings Release-$0.84-$1.03 to -$0.76-$0.95
May 9, 2022Q1 2022 Earnings Release-$0.22-$0.96 to -$0.39-$0.67
March 3, 2022Q4 2021 Earnings Release-$0.45-$1.01 to -$0.73-$0.73

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

, , , Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.